Kymera Therapeutics Director Bruce Booth Offloads $45.3M in Shares Amid Stock Surge
Bruce Booth, a director at Kymera Therapeutics, Inc. (NASDAQ:KYMR), executed a series of stock transactions totaling approximately $45.3 million between June 17 and June 22, 2026. The sales, which include both direct exercises of vested options and indirect sales through affiliated funds, were conducted under pre-established Rule 10b5-1 trading pla…